The store will not work correctly when cookies are disabled.
2-(2-Bromo-phenylimino)-5-(quinolin-6-ylmethylene)-thiazolidin-4-one
ID: ALA3728543
PubChem CID: 136059521
Max Phase: Preclinical
Molecular Formula: C19H12BrN3OS
Molecular Weight: 410.30
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C1N/C(=N/c2ccccc2Br)S/C1=C\c1ccc2ncccc2c1
Standard InChI: InChI=1S/C19H12BrN3OS/c20-14-5-1-2-6-16(14)22-19-23-18(24)17(25-19)11-12-7-8-15-13(10-12)4-3-9-21-15/h1-11H,(H,22,23,24)/b17-11-
Standard InChI Key: GDRMNTFZVIQOBU-BOPFTXTBSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
-1.2964 -1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2964 1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6111 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6111 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 -1.4973 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5929 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5929 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9122 1.4966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2109 0.7445 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.3439 -0.7369 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-6.8101 -1.0536 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.5644 0.2430 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-6.5644 1.3610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.8108 2.5355 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-7.4178 -2.4230 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-6.5350 -3.6367 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.0435 -3.4761 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.1587 -4.6873 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.7652 -6.0592 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.2566 -6.2199 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.1414 -5.0087 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-8.3345 -5.1373 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
1 6 2 0
5 2 2 0
2 3 1 0
3 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
3 11 1 0
11 12 2 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 12 1 0
16 17 2 0
14 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
24 25 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 410.30 | Molecular Weight (Monoisotopic): 408.9884 | AlogP: 4.89 | #Rotatable Bonds: 2 |
Polar Surface Area: 54.35 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.85 | CX Basic pKa: 4.44 | CX LogP: 4.84 | CX LogD: 4.84 |
Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.61 | Np Likeness Score: -1.61 |
References
1. (2010) Chemical compounds, |